Abstract A unicyanobacterial isolate of cyanobacterium, identified as Microcystis Ku2, produced a mammalian elastase-inhibitory lipid derivative. Protease inhibitors in cyanobacteria are unequivocally peptides. Since this metabolite appeared in lipid phase, we worked on a hypothesis that whether metabolite other than peptides could be responsible for the characteristic inhibition. It was purified by saponification and reverse phase column chromatography. The resulting compound was tentatively characterized as a glycolipid with structure of sulfated dipentose derivative of ceramide (MW = 956 Da). The apparent IC 50 for elastase was 1.3 lM.
Introduction
Microcystis sp. produces a variety of linear-and depsipeptides (cyanopeptolins, aeruginosins, microviridins etc.) inhibiting mammalian serine proteases viz. trypsin, thrombin, chymotrypsin and elastase [1] . Usually, abundance of such metabolites in natural population is recorded by MS techniques, mainly the MALDI-TOF, and subsequently clonal cultures of Microcystis sp. are raised for further characterization of the specific protease inhibitor. Since isolated Microcystis sp. in lab cultures do not maintained any of the colonial morphological features that they show in nature, PCR amplification of Microcystis genus-specific 16S rRNA gene becomes necessary to confirm their identify unequivocally [2] .
Earlier, we have isolated a unicyanobacterial strain of Microcystis Ku1 from a local water body, and characterized a trypsin-inhibitory metabolite, microviridin [3] . Another strain, termed Microcystis Ku2, was found to strongly inhibit porcine pancreas elastase activity. In this communication, we have purified and characterized a novel elastase-inhibitory lipid derivative from cyanobacterium.
Materials and Methods
Several clonal strains of Microcystis were raised to unicyanobacterial state from a M. aeruginosa-dominant phytoplankton material collected in 1999 from a nearby Kundam lake [4] , and were routinely grown in Parker's medium. The purity of the cultures was verified by using phase-contrast and bright field microscopy and by plating aliquots of the cultures on Luria-Bertani medium. One such strain, Microcystis Ku1, was characterized earlier [3] . Another strain, subsequently identified as Microcystis Ku2, was used in present investigation. Cells from ca. 5 l cultures were harvested by centrifugation (3,0009g) The freeze-dried cell material (0.5 g dry weight) was extracted with three batches of 40 ml of methanol. The supernatant was then evaporated under vacuum, and the residue dissolved in 0.5 ml of 20% methanol. For inhibition tests, methanolic extracts corresponding to 0.2 mg dry wt of original cell mass or equivalent methanol were added to 1 ml of elastase (Type IV porcine pancreas; Sigma E0258) assay mixture [6] .
Elastase-inhibitory metabolite from Microcystis Ku2 was purified by modification of Bagchi and Ray [7] . Methanolic extract (250 ml) corresponding to 5 g dry wt was refluxed for 6-8 h at 85°C with 2.5% of KOH and the condensed fraction was hydrolyzed with 15 ml of 0.1 M HCl at 45°C. The GF/C filtered above fraction and the left out methanol were tenfold diluted with de-ionized water and passed through LiChrolut RP-18 (ODS) cartridges (Merck, Germany; 500 mg sorbent). After 20% methanol wash, the bound material was eluted with 20 ml methanol, dried and the residues dissolved in 0.2 ml methanol. Elastase inhibitory metabolite so collected was purified on a HPLC (Shimadzu LC 10AT, Japan) using 250 9 4.6 mm column (Phenomenex Type Luna 5 lm C-18, USA) and methanol: acetonitrile: water (7:2:1 v/v) solvent system at a flow rate of 1 ml min
. Compounds were detected using a photodiode array detector (SPD-M10AVP, Shimadzu, Japan) at 220 nm. One ml fractions corresponding to the peak positions were collected, dried, weighed and re-dissolved in 1 ml of 50% methanol. Aliquots equivalent to 20 lg dry wt of the residue were assayed for their ability to inhibit elastase. IC 50 values were calculated from dosedependent curve using Microsoft Excel Ò . The assays were carried out at least in triplicate and the values were averaged. TLC of the active fractions was carried out to identify the compound(s). The plates were developed with hexane, diethyl ether and acetic acid (8:2:0.1 v/v), and sugar-containing lipids were detected by 2.2% diphenylamine in acetone, aniline and phosphoric acid (9:0.1:0.1 v/v). ESI MS experiments were performed on a Quattro II TOFSPEC2E Micromass triple quadrupole mass spectrometer. Samples were dissolved in 1:1 (v/v) aqueous methanol. Electrospray samples were typically introduced into the mass analyzer through a syringe pump at a rate of 5 ll min -1 . The ESI capillary was set at 3.5 kV and the cone voltage was at 40 kV.
1 H NMR was carried out in CDCl 3 solvent using Bruker DRX-300.
Results and Discussion
A unicyanobacterial culture of putative Microcystis Ku2 consisted of single spherical cells (diameter 4.5 lm, with a fine gelatinous sheath) and a few doublets. The cells grew with a generation time of approx 56 h. For an authentication of identity of the strain, amplification of Microcystis-specific 16S rRNA gene was carried out. M. aeruginosa PCC7806 and S. elongatus PCC7942 were used as positive and negative controls, respectively. The MIC-PCR reactions revealed amplification of ca. 240-bp fragment for both the strains (Fig. 1) .
The Microcystis Ku2 cells in lab conditions consistently produced an elastase inhibitory metabolite. Absence of apparent bacterial contamination indicated the metabolite to be of cyanobacterial origin. The recognized elastaseinhibitory metabolites in cyanobacteria are invariably the peptides-cyanopeptolins (scyptolins, planktopeptins etc.) and microviridins with Leu and other hydrophobic moieties [8] [9] [10] . Since it is possible to recognize these peptides from their diagnostic peaks by MALDI-TOF MS [11, 12] , a spectrum of the dried cells of Microcystis Ku2 was run. As shown in Fig. 2 , signals of neither class of the peptides were detected, albeit prominent signals between m/z 655 and 720 did appear, which were identified as unknown lipids (M. Erhard, personal communication). Abundance of high lipid content was rather unique for this strain, and has not been observed in the other lab cultures. It was reasonable to assume that the putative elastase inhibitor is a lipid compound, rather than a peptide. The compound was soluble in methanol and other polar solvents, and during saponification it got resolved into the condensed fraction, (Figs. 3, 4) . Re-chromatography of this fraction yielded single peak. Upon TLC the residue collected from this elute gave positive reaction for glycolipids as a single spot at apparent Rf = 0.5. From 0.5 g of dry cells ca. 38 mg of purified elastase inhibitor was recovered.
Upon 1 H NMR, the spectrum of the purified sample (Fig. 5 ) was quite characteristic of fatty acid derivative, i.e. a triplet at d 0.879, and two singlets at d 1.28 and 1.64 were detected, which represent protons of -CH 3 , and -(CH 2 ) n -. The nature of other minor signals could not be elucidated. The spectrum did not match with any of the known cyanopeptides. Using ESI MS the molecular ion peak also appeared at m/z 956. The fragmentation pattern of this compound is shown in Fig. 6 , which can be explained as follows (S. Antonopoulou, personal communication): the fragment at m/z 467 corresponds to a di-pentose where three OH-groups have been substituted with two SO 3 H-and one CH 3 CO-groups. This conclusion is supported by the existence of m/z 255 corresponding to terminal sugar, which upon fragmentation gave rise to m/z 157 and 197 after the removal of SO 3 H-and CH 3 CO-groups, respectively. Removal of terminal sugar from the molecule gave rise to fragment at m/z 702, which corresponds to the second pentose with an SO 3 H-group linked with a ceramide. The structure of the ceramide can not be predicted but assuming the presence of the classical sphingoid chain, the fatty acid chain is expected to be (CH 3 CH 2 ) 5 (CH=CH) 3 CO-. The most probable structure of the compound is a sulfated dipentose derivative of a ceramide (MW = 956 Da) (Fig. 6) .
Further, infrared spectrum of the sample was consistent with the proposed structure, particularly the signals at 1352-1342, 1165-1150 and 910-895 cm -1 , characteristic of asymmetric SO 2 stretch, symmetric SO 2 stretch and S ? O stretch, respectively (data not shown).
To best of our knowledge this is first report of an elastase-inhibitory lipid derivative from cyanobacteria. Sulfatecontaining glycolipids have been characterized as platelet aggregating factors [13] . Sulfated heparin and its analogues present in blood are strong neutrophil elastase inhibitors [14] . Possibly sulfated di-pentose also has the same function, and the ceramide moiety helps this molecule to bind to the membranes. At the moment, it is difficult to predict upon the function of this metabolite, except that it may serve as a grazing-deterrent substance. Molecules of such large size can not be excreted from the phytoplankton cells, but once ingested, are probably hydrolysed by some esterase action of enzyme cocktail of animal gut, and the released sulfated sugar might inactivate the proteases. Large Cladocera like Moina and Daphnia graze on planktonic cyanobacteria, including, Microcystis. Further, mammalian elastase-like activity has been shown in the body homogenate of Moina macrocopa [15] . Further work on anti-inflammatory activity of the metabolite would be desirous, especially because it is produced from a non-toxic strain (absence of microcystins, cf. Fig. 2 ).
